1 The following narcotics may not be cultivated, imported, produced or placed on the market:35
- a.
- opium for smoking and the residues created in its production or use;
- b.
- diacetylmorphine and its salts;
- c.
- hallucinogens such as lysergide (LSD 25);
- d.36
- narcotics containing an effective concentration of cannabinoids.37
2 ...38
3 The Federal Council may prohibit the import, production and placing on the market of further narcotics if international agreements prohibit their production or the most important producer countries cease their production.39
4 Any stocks of prohibited narcotics must be transformed under the supervision of the relevant cantonal authority in to a legally-permitted substance or, if this is not possible, destroyed.
5 The Federal Office of Public Health may issue exceptional licences for cultivating, importing, producing and placing on the market the narcotics mentioned in paragraphs 1 and 3, where this is not prohibited by an international agreement and these narcotics are needed for scientific research, the development of medicinal products or for restricted medical use.40
6 For the cultivation of a narcotic mentioned in paragraphs 1 and 3 that is an active ingredient in an authorised medicinal product, an exceptional licence is required from the Federal Office of Public Health.41
7 For the import, production and placing on the market of a narcotic mentioned in paragraphs 1 and 3 that is an active ingredient in an authorised medicinal product, a licence is required from the Agency in accordance with Article 4.42
8 The Federal Office of Public Health may grant exceptional licences, provided the substances mentioned in the paragraphs 1 and 3 are used in control measures.43